nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorthalidone—Tubulointerstitial nephritis—Ifosfamide—testicular cancer	0.0147	0.0147	CcSEcCtD
Chlorthalidone—Vasculitis—Ifosfamide—testicular cancer	0.0115	0.0115	CcSEcCtD
Chlorthalidone—Aplastic anaemia—Dactinomycin—testicular cancer	0.0115	0.0115	CcSEcCtD
Chlorthalidone—Toxic epidermal necrolysis—Chlorambucil—testicular cancer	0.0111	0.0111	CcSEcCtD
Chlorthalidone—Appetite absent—Methotrexate—testicular cancer	0.0107	0.0107	CcSEcCtD
Chlorthalidone—Hyperuricaemia—Cisplatin—testicular cancer	0.0105	0.0105	CcSEcCtD
Chlorthalidone—Pulmonary oedema—Ifosfamide—testicular cancer	0.01	0.01	CcSEcCtD
Chlorthalidone—Blood uric acid increased—Cisplatin—testicular cancer	0.00988	0.00988	CcSEcCtD
Chlorthalidone—Hyperuricaemia—Etoposide—testicular cancer	0.00958	0.00958	CcSEcCtD
Chlorthalidone—Jaundice—Chlorambucil—testicular cancer	0.00928	0.00928	CcSEcCtD
Chlorthalidone—Blood uric acid increased—Etoposide—testicular cancer	0.00905	0.00905	CcSEcCtD
Chlorthalidone—Agranulocytosis—Vinblastine—testicular cancer	0.00814	0.00814	CcSEcCtD
Chlorthalidone—Toxic epidermal necrolysis—Dactinomycin—testicular cancer	0.00803	0.00803	CcSEcCtD
Chlorthalidone—Hypomagnesaemia—Epirubicin—testicular cancer	0.00785	0.00785	CcSEcCtD
Chlorthalidone—Hypokalaemia—Ifosfamide—testicular cancer	0.00744	0.00744	CcSEcCtD
Chlorthalidone—Toxic epidermal necrolysis—Ifosfamide—testicular cancer	0.00736	0.00736	CcSEcCtD
Chlorthalidone—Hypomagnesaemia—Doxorubicin—testicular cancer	0.00726	0.00726	CcSEcCtD
Chlorthalidone—Hypercalcaemia—Epirubicin—testicular cancer	0.00717	0.00717	CcSEcCtD
Chlorthalidone—Hyponatraemia—Cisplatin—testicular cancer	0.00707	0.00707	CcSEcCtD
Chlorthalidone—Pancreatitis—Ifosfamide—testicular cancer	0.00692	0.00692	CcSEcCtD
Chlorthalidone—Agitation—Chlorambucil—testicular cancer	0.00684	0.00684	CcSEcCtD
Chlorthalidone—Leukopenia—Chlorambucil—testicular cancer	0.00666	0.00666	CcSEcCtD
Chlorthalidone—Hypercalcaemia—Doxorubicin—testicular cancer	0.00664	0.00664	CcSEcCtD
Chlorthalidone—Orthostatic hypotension—Cisplatin—testicular cancer	0.00643	0.00643	CcSEcCtD
Chlorthalidone—Agranulocytosis—Dactinomycin—testicular cancer	0.00641	0.00641	CcSEcCtD
Chlorthalidone—Hypokalaemia—Cisplatin—testicular cancer	0.00641	0.00641	CcSEcCtD
Chlorthalidone—Hyperglycaemia—Ifosfamide—testicular cancer	0.00637	0.00637	CcSEcCtD
Chlorthalidone—Cramp muscle—Cisplatin—testicular cancer	0.00634	0.00634	CcSEcCtD
Chlorthalidone—Glycosuria—Epirubicin—testicular cancer	0.00615	0.00615	CcSEcCtD
Chlorthalidone—Vertigo—Vinblastine—testicular cancer	0.00613	0.00613	CcSEcCtD
Chlorthalidone—Leukopenia—Vinblastine—testicular cancer	0.0061	0.0061	CcSEcCtD
Chlorthalidone—Pancreatitis—Cisplatin—testicular cancer	0.00597	0.00597	CcSEcCtD
Chlorthalidone—Thrombocytopenia—Chlorambucil—testicular cancer	0.00594	0.00594	CcSEcCtD
Chlorthalidone—Agranulocytosis—Ifosfamide—testicular cancer	0.00588	0.00588	CcSEcCtD
Chlorthalidone—Abdominal discomfort—Cisplatin—testicular cancer	0.00584	0.00584	CcSEcCtD
Chlorthalidone—Cramp muscle—Etoposide—testicular cancer	0.00581	0.00581	CcSEcCtD
Chlorthalidone—Toxic epidermal necrolysis—Etoposide—testicular cancer	0.00581	0.00581	CcSEcCtD
Chlorthalidone—Anorexia—Chlorambucil—testicular cancer	0.00579	0.00579	CcSEcCtD
Chlorthalidone—Hyperuricaemia—Methotrexate—testicular cancer	0.00574	0.00574	CcSEcCtD
Chlorthalidone—Glycosuria—Doxorubicin—testicular cancer	0.00569	0.00569	CcSEcCtD
Chlorthalidone—Jaundice cholestatic—Epirubicin—testicular cancer	0.00567	0.00567	CcSEcCtD
Chlorthalidone—Vasculitis—Methotrexate—testicular cancer	0.00546	0.00546	CcSEcCtD
Chlorthalidone—Thrombocytopenia—Vinblastine—testicular cancer	0.00545	0.00545	CcSEcCtD
Chlorthalidone—Blood uric acid increased—Methotrexate—testicular cancer	0.00542	0.00542	CcSEcCtD
Chlorthalidone—Hyperuricaemia—Epirubicin—testicular cancer	0.00537	0.00537	CcSEcCtD
Chlorthalidone—Anorexia—Vinblastine—testicular cancer	0.0053	0.0053	CcSEcCtD
Chlorthalidone—Decreased appetite—Chlorambucil—testicular cancer	0.00528	0.00528	CcSEcCtD
Chlorthalidone—Jaundice cholestatic—Doxorubicin—testicular cancer	0.00525	0.00525	CcSEcCtD
Chlorthalidone—Leukopenia—Bleomycin—testicular cancer	0.00515	0.00515	CcSEcCtD
Chlorthalidone—Blood uric acid increased—Epirubicin—testicular cancer	0.00508	0.00508	CcSEcCtD
Chlorthalidone—Arrhythmia—Ifosfamide—testicular cancer	0.00505	0.00505	CcSEcCtD
Chlorthalidone—Aplastic anaemia—Methotrexate—testicular cancer	0.005	0.005	CcSEcCtD
Chlorthalidone—Paraesthesia—Vinblastine—testicular cancer	0.005	0.005	CcSEcCtD
Chlorthalidone—Hyperuricaemia—Doxorubicin—testicular cancer	0.00497	0.00497	CcSEcCtD
Chlorthalidone—Jaundice—Etoposide—testicular cancer	0.00485	0.00485	CcSEcCtD
Chlorthalidone—Decreased appetite—Vinblastine—testicular cancer	0.00484	0.00484	CcSEcCtD
Chlorthalidone—Urticaria—Chlorambucil—testicular cancer	0.00482	0.00482	CcSEcCtD
Chlorthalidone—Leukopenia—Dactinomycin—testicular cancer	0.00481	0.00481	CcSEcCtD
Chlorthalidone—Abdominal pain—Chlorambucil—testicular cancer	0.0048	0.0048	CcSEcCtD
Chlorthalidone—Constipation—Vinblastine—testicular cancer	0.00476	0.00476	CcSEcCtD
Chlorthalidone—Pulmonary oedema—Methotrexate—testicular cancer	0.00474	0.00474	CcSEcCtD
Chlorthalidone—Blood uric acid increased—Doxorubicin—testicular cancer	0.0047	0.0047	CcSEcCtD
Chlorthalidone—Aplastic anaemia—Epirubicin—testicular cancer	0.00468	0.00468	CcSEcCtD
Chlorthalidone—Agranulocytosis—Etoposide—testicular cancer	0.00464	0.00464	CcSEcCtD
Chlorthalidone—Thrombocytopenia—Bleomycin—testicular cancer	0.0046	0.0046	CcSEcCtD
Chlorthalidone—Agitation—Ifosfamide—testicular cancer	0.00452	0.00452	CcSEcCtD
Chlorthalidone—Anorexia—Bleomycin—testicular cancer	0.00448	0.00448	CcSEcCtD
Chlorthalidone—Hypersensitivity—Chlorambucil—testicular cancer	0.00447	0.00447	CcSEcCtD
Chlorthalidone—Diabetes mellitus—Methotrexate—testicular cancer	0.00444	0.00444	CcSEcCtD
Chlorthalidone—Pulmonary oedema—Epirubicin—testicular cancer	0.00444	0.00444	CcSEcCtD
Chlorthalidone—Vertigo—Ifosfamide—testicular cancer	0.00442	0.00442	CcSEcCtD
Chlorthalidone—Leukopenia—Ifosfamide—testicular cancer	0.0044	0.0044	CcSEcCtD
Chlorthalidone—Photosensitivity—Methotrexate—testicular cancer	0.0044	0.0044	CcSEcCtD
Chlorthalidone—Abdominal pain—Vinblastine—testicular cancer	0.0044	0.0044	CcSEcCtD
Chlorthalidone—Asthenia—Chlorambucil—testicular cancer	0.00436	0.00436	CcSEcCtD
Chlorthalidone—Arrhythmia—Cisplatin—testicular cancer	0.00435	0.00435	CcSEcCtD
Chlorthalidone—Aplastic anaemia—Doxorubicin—testicular cancer	0.00433	0.00433	CcSEcCtD
Chlorthalidone—Thrombocytopenia—Dactinomycin—testicular cancer	0.00429	0.00429	CcSEcCtD
Chlorthalidone—Paraesthesia—Bleomycin—testicular cancer	0.00422	0.00422	CcSEcCtD
Chlorthalidone—Anorexia—Dactinomycin—testicular cancer	0.00418	0.00418	CcSEcCtD
Chlorthalidone—Diabetes mellitus—Epirubicin—testicular cancer	0.00416	0.00416	CcSEcCtD
Chlorthalidone—Diarrhoea—Chlorambucil—testicular cancer	0.00415	0.00415	CcSEcCtD
Chlorthalidone—Photosensitivity—Epirubicin—testicular cancer	0.00412	0.00412	CcSEcCtD
Chlorthalidone—Pulmonary oedema—Doxorubicin—testicular cancer	0.0041	0.0041	CcSEcCtD
Chlorthalidone—Hypersensitivity—Vinblastine—testicular cancer	0.0041	0.0041	CcSEcCtD
Chlorthalidone—Decreased appetite—Bleomycin—testicular cancer	0.00409	0.00409	CcSEcCtD
Chlorthalidone—Muscle spasms—Cisplatin—testicular cancer	0.00408	0.00408	CcSEcCtD
Chlorthalidone—Vascular purpura—Epirubicin—testicular cancer	0.00404	0.00404	CcSEcCtD
Chlorthalidone—Asthenia—Vinblastine—testicular cancer	0.00399	0.00399	CcSEcCtD
Chlorthalidone—Thrombocytopenia—Ifosfamide—testicular cancer	0.00393	0.00393	CcSEcCtD
Chlorthalidone—Vomiting—Chlorambucil—testicular cancer	0.00386	0.00386	CcSEcCtD
Chlorthalidone—Diabetes mellitus—Doxorubicin—testicular cancer	0.00385	0.00385	CcSEcCtD
Chlorthalidone—Anorexia—Ifosfamide—testicular cancer	0.00383	0.00383	CcSEcCtD
Chlorthalidone—Photosensitivity—Doxorubicin—testicular cancer	0.00381	0.00381	CcSEcCtD
Chlorthalidone—Decreased appetite—Dactinomycin—testicular cancer	0.00381	0.00381	CcSEcCtD
Chlorthalidone—Diarrhoea—Vinblastine—testicular cancer	0.00381	0.00381	CcSEcCtD
Chlorthalidone—Leukopenia—Cisplatin—testicular cancer	0.0038	0.0038	CcSEcCtD
Chlorthalidone—Purpura—Epirubicin—testicular cancer	0.00375	0.00375	CcSEcCtD
Chlorthalidone—Vascular purpura—Doxorubicin—testicular cancer	0.00374	0.00374	CcSEcCtD
Chlorthalidone—Muscle spasms—Etoposide—testicular cancer	0.00374	0.00374	CcSEcCtD
Chlorthalidone—Urticaria—Bleomycin—testicular cancer	0.00373	0.00373	CcSEcCtD
Chlorthalidone—Dizziness—Vinblastine—testicular cancer	0.00368	0.00368	CcSEcCtD
Chlorthalidone—Hyponatraemia—Epirubicin—testicular cancer	0.00363	0.00363	CcSEcCtD
Chlorthalidone—Nausea—Chlorambucil—testicular cancer	0.00361	0.00361	CcSEcCtD
Chlorthalidone—Paraesthesia—Ifosfamide—testicular cancer	0.00361	0.00361	CcSEcCtD
Chlorthalidone—Vomiting—Vinblastine—testicular cancer	0.00354	0.00354	CcSEcCtD
Chlorthalidone—Vertigo—Etoposide—testicular cancer	0.00349	0.00349	CcSEcCtD
Chlorthalidone—Decreased appetite—Ifosfamide—testicular cancer	0.00349	0.00349	CcSEcCtD
Chlorthalidone—Headache—Vinblastine—testicular cancer	0.00349	0.00349	CcSEcCtD
Chlorthalidone—Toxic epidermal necrolysis—Methotrexate—testicular cancer	0.00348	0.00348	CcSEcCtD
Chlorthalidone—Leukopenia—Etoposide—testicular cancer	0.00348	0.00348	CcSEcCtD
Chlorthalidone—Purpura—Doxorubicin—testicular cancer	0.00347	0.00347	CcSEcCtD
Chlorthalidone—Abdominal pain—Dactinomycin—testicular cancer	0.00346	0.00346	CcSEcCtD
Chlorthalidone—Hypersensitivity—Bleomycin—testicular cancer	0.00346	0.00346	CcSEcCtD
Chlorthalidone—Constipation—Ifosfamide—testicular cancer	0.00343	0.00343	CcSEcCtD
Chlorthalidone—Thrombocytopenia—Cisplatin—testicular cancer	0.00339	0.00339	CcSEcCtD
Chlorthalidone—Asthenia—Bleomycin—testicular cancer	0.00337	0.00337	CcSEcCtD
Chlorthalidone—Hyponatraemia—Doxorubicin—testicular cancer	0.00336	0.00336	CcSEcCtD
Chlorthalidone—Eosinophilia—Methotrexate—testicular cancer	0.00331	0.00331	CcSEcCtD
Chlorthalidone—Nausea—Vinblastine—testicular cancer	0.00331	0.00331	CcSEcCtD
Chlorthalidone—Abdominal pain upper—Epirubicin—testicular cancer	0.0033	0.0033	CcSEcCtD
Chlorthalidone—Orthostatic hypotension—Epirubicin—testicular cancer	0.0033	0.0033	CcSEcCtD
Chlorthalidone—Anorexia—Cisplatin—testicular cancer	0.0033	0.0033	CcSEcCtD
Chlorthalidone—Hypokalaemia—Epirubicin—testicular cancer	0.00329	0.00329	CcSEcCtD
Chlorthalidone—Pancreatitis—Methotrexate—testicular cancer	0.00328	0.00328	CcSEcCtD
Chlorthalidone—Toxic epidermal necrolysis—Epirubicin—testicular cancer	0.00326	0.00326	CcSEcCtD
Chlorthalidone—Hypersensitivity—Dactinomycin—testicular cancer	0.00323	0.00323	CcSEcCtD
Chlorthalidone—Abdominal discomfort—Methotrexate—testicular cancer	0.0032	0.0032	CcSEcCtD
Chlorthalidone—Urticaria—Ifosfamide—testicular cancer	0.00319	0.00319	CcSEcCtD
Chlorthalidone—Abdominal pain—Ifosfamide—testicular cancer	0.00317	0.00317	CcSEcCtD
Chlorthalidone—Asthenia—Dactinomycin—testicular cancer	0.00314	0.00314	CcSEcCtD
Chlorthalidone—Paraesthesia—Cisplatin—testicular cancer	0.00311	0.00311	CcSEcCtD
Chlorthalidone—Thrombocytopenia—Etoposide—testicular cancer	0.00311	0.00311	CcSEcCtD
Chlorthalidone—Eosinophilia—Epirubicin—testicular cancer	0.0031	0.0031	CcSEcCtD
Chlorthalidone—Erectile dysfunction—Methotrexate—testicular cancer	0.00308	0.00308	CcSEcCtD
Chlorthalidone—Pancreatitis—Epirubicin—testicular cancer	0.00307	0.00307	CcSEcCtD
Chlorthalidone—Abdominal pain upper—Doxorubicin—testicular cancer	0.00306	0.00306	CcSEcCtD
Chlorthalidone—Orthostatic hypotension—Doxorubicin—testicular cancer	0.00306	0.00306	CcSEcCtD
Chlorthalidone—Photosensitivity reaction—Methotrexate—testicular cancer	0.00305	0.00305	CcSEcCtD
Chlorthalidone—Hypokalaemia—Doxorubicin—testicular cancer	0.00305	0.00305	CcSEcCtD
Chlorthalidone—Anorexia—Etoposide—testicular cancer	0.00302	0.00302	CcSEcCtD
Chlorthalidone—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.00301	0.00301	CcSEcCtD
Chlorthalidone—Decreased appetite—Cisplatin—testicular cancer	0.00301	0.00301	CcSEcCtD
Chlorthalidone—Diarrhoea—Dactinomycin—testicular cancer	0.003	0.003	CcSEcCtD
Chlorthalidone—Vomiting—Bleomycin—testicular cancer	0.00299	0.00299	CcSEcCtD
Chlorthalidone—Rash—Bleomycin—testicular cancer	0.00296	0.00296	CcSEcCtD
Chlorthalidone—Dermatitis—Bleomycin—testicular cancer	0.00296	0.00296	CcSEcCtD
Chlorthalidone—Hypersensitivity—Ifosfamide—testicular cancer	0.00296	0.00296	CcSEcCtD
Chlorthalidone—Asthenia—Ifosfamide—testicular cancer	0.00288	0.00288	CcSEcCtD
Chlorthalidone—Eosinophilia—Doxorubicin—testicular cancer	0.00286	0.00286	CcSEcCtD
Chlorthalidone—Photosensitivity reaction—Epirubicin—testicular cancer	0.00285	0.00285	CcSEcCtD
Chlorthalidone—Paraesthesia—Etoposide—testicular cancer	0.00285	0.00285	CcSEcCtD
Chlorthalidone—Pancreatitis—Doxorubicin—testicular cancer	0.00284	0.00284	CcSEcCtD
Chlorthalidone—Hyperglycaemia—Epirubicin—testicular cancer	0.00282	0.00282	CcSEcCtD
Chlorthalidone—Nausea—Bleomycin—testicular cancer	0.00279	0.00279	CcSEcCtD
Chlorthalidone—Vomiting—Dactinomycin—testicular cancer	0.00279	0.00279	CcSEcCtD
Chlorthalidone—Agranulocytosis—Methotrexate—testicular cancer	0.00278	0.00278	CcSEcCtD
Chlorthalidone—Rash—Dactinomycin—testicular cancer	0.00276	0.00276	CcSEcCtD
Chlorthalidone—Decreased appetite—Etoposide—testicular cancer	0.00276	0.00276	CcSEcCtD
Chlorthalidone—Diarrhoea—Ifosfamide—testicular cancer	0.00275	0.00275	CcSEcCtD
Chlorthalidone—Jaundice—Epirubicin—testicular cancer	0.00272	0.00272	CcSEcCtD
Chlorthalidone—Constipation—Etoposide—testicular cancer	0.00271	0.00271	CcSEcCtD
Chlorthalidone—Dizziness—Ifosfamide—testicular cancer	0.00266	0.00266	CcSEcCtD
Chlorthalidone—Photosensitivity reaction—Doxorubicin—testicular cancer	0.00264	0.00264	CcSEcCtD
Chlorthalidone—Hyperglycaemia—Doxorubicin—testicular cancer	0.00261	0.00261	CcSEcCtD
Chlorthalidone—Nausea—Dactinomycin—testicular cancer	0.0026	0.0026	CcSEcCtD
Chlorthalidone—Agranulocytosis—Epirubicin—testicular cancer	0.0026	0.0026	CcSEcCtD
Chlorthalidone—Vomiting—Ifosfamide—testicular cancer	0.00255	0.00255	CcSEcCtD
Chlorthalidone—Hypersensitivity—Cisplatin—testicular cancer	0.00255	0.00255	CcSEcCtD
Chlorthalidone—Rash—Ifosfamide—testicular cancer	0.00253	0.00253	CcSEcCtD
Chlorthalidone—Dermatitis—Ifosfamide—testicular cancer	0.00253	0.00253	CcSEcCtD
Chlorthalidone—Urticaria—Etoposide—testicular cancer	0.00252	0.00252	CcSEcCtD
Chlorthalidone—Jaundice—Doxorubicin—testicular cancer	0.00251	0.00251	CcSEcCtD
Chlorthalidone—Abdominal pain—Etoposide—testicular cancer	0.00251	0.00251	CcSEcCtD
Chlorthalidone—Asthenia—Cisplatin—testicular cancer	0.00248	0.00248	CcSEcCtD
Chlorthalidone—Agranulocytosis—Doxorubicin—testicular cancer	0.00241	0.00241	CcSEcCtD
Chlorthalidone—Nausea—Ifosfamide—testicular cancer	0.00239	0.00239	CcSEcCtD
Chlorthalidone—Diarrhoea—Cisplatin—testicular cancer	0.00237	0.00237	CcSEcCtD
Chlorthalidone—Hypersensitivity—Etoposide—testicular cancer	0.00234	0.00234	CcSEcCtD
Chlorthalidone—Asthenia—Etoposide—testicular cancer	0.00228	0.00228	CcSEcCtD
Chlorthalidone—Arrhythmia—Epirubicin—testicular cancer	0.00224	0.00224	CcSEcCtD
Chlorthalidone—Vomiting—Cisplatin—testicular cancer	0.0022	0.0022	CcSEcCtD
Chlorthalidone—Rash—Cisplatin—testicular cancer	0.00218	0.00218	CcSEcCtD
Chlorthalidone—Dermatitis—Cisplatin—testicular cancer	0.00218	0.00218	CcSEcCtD
Chlorthalidone—Diarrhoea—Etoposide—testicular cancer	0.00217	0.00217	CcSEcCtD
Chlorthalidone—Dizziness—Etoposide—testicular cancer	0.0021	0.0021	CcSEcCtD
Chlorthalidone—Muscle spasms—Epirubicin—testicular cancer	0.00209	0.00209	CcSEcCtD
Chlorthalidone—Vertigo—Methotrexate—testicular cancer	0.00209	0.00209	CcSEcCtD
Chlorthalidone—Leukopenia—Methotrexate—testicular cancer	0.00208	0.00208	CcSEcCtD
Chlorthalidone—Arrhythmia—Doxorubicin—testicular cancer	0.00207	0.00207	CcSEcCtD
Chlorthalidone—Nausea—Cisplatin—testicular cancer	0.00206	0.00206	CcSEcCtD
Chlorthalidone—Vomiting—Etoposide—testicular cancer	0.00202	0.00202	CcSEcCtD
Chlorthalidone—Agitation—Epirubicin—testicular cancer	0.002	0.002	CcSEcCtD
Chlorthalidone—Rash—Etoposide—testicular cancer	0.002	0.002	CcSEcCtD
Chlorthalidone—Dermatitis—Etoposide—testicular cancer	0.002	0.002	CcSEcCtD
Chlorthalidone—Headache—Etoposide—testicular cancer	0.00199	0.00199	CcSEcCtD
Chlorthalidone—Vertigo—Epirubicin—testicular cancer	0.00196	0.00196	CcSEcCtD
Chlorthalidone—Leukopenia—Epirubicin—testicular cancer	0.00195	0.00195	CcSEcCtD
Chlorthalidone—Muscle spasms—Doxorubicin—testicular cancer	0.00194	0.00194	CcSEcCtD
Chlorthalidone—Nausea—Etoposide—testicular cancer	0.00188	0.00188	CcSEcCtD
Chlorthalidone—Thrombocytopenia—Methotrexate—testicular cancer	0.00186	0.00186	CcSEcCtD
Chlorthalidone—Agitation—Doxorubicin—testicular cancer	0.00185	0.00185	CcSEcCtD
Chlorthalidone—Vertigo—Doxorubicin—testicular cancer	0.00181	0.00181	CcSEcCtD
Chlorthalidone—Anorexia—Methotrexate—testicular cancer	0.00181	0.00181	CcSEcCtD
Chlorthalidone—Leukopenia—Doxorubicin—testicular cancer	0.0018	0.0018	CcSEcCtD
Chlorthalidone—Thrombocytopenia—Epirubicin—testicular cancer	0.00174	0.00174	CcSEcCtD
Chlorthalidone—Paraesthesia—Methotrexate—testicular cancer	0.00171	0.00171	CcSEcCtD
Chlorthalidone—Anorexia—Epirubicin—testicular cancer	0.00169	0.00169	CcSEcCtD
Chlorthalidone—Decreased appetite—Methotrexate—testicular cancer	0.00165	0.00165	CcSEcCtD
Chlorthalidone—Thrombocytopenia—Doxorubicin—testicular cancer	0.00161	0.00161	CcSEcCtD
Chlorthalidone—Paraesthesia—Epirubicin—testicular cancer	0.0016	0.0016	CcSEcCtD
Chlorthalidone—Anorexia—Doxorubicin—testicular cancer	0.00157	0.00157	CcSEcCtD
Chlorthalidone—Decreased appetite—Epirubicin—testicular cancer	0.00155	0.00155	CcSEcCtD
Chlorthalidone—Constipation—Epirubicin—testicular cancer	0.00152	0.00152	CcSEcCtD
Chlorthalidone—Urticaria—Methotrexate—testicular cancer	0.00151	0.00151	CcSEcCtD
Chlorthalidone—Abdominal pain—Methotrexate—testicular cancer	0.0015	0.0015	CcSEcCtD
Chlorthalidone—Paraesthesia—Doxorubicin—testicular cancer	0.00148	0.00148	CcSEcCtD
Chlorthalidone—Decreased appetite—Doxorubicin—testicular cancer	0.00143	0.00143	CcSEcCtD
Chlorthalidone—Urticaria—Epirubicin—testicular cancer	0.00141	0.00141	CcSEcCtD
Chlorthalidone—Constipation—Doxorubicin—testicular cancer	0.00141	0.00141	CcSEcCtD
Chlorthalidone—Abdominal pain—Epirubicin—testicular cancer	0.00141	0.00141	CcSEcCtD
Chlorthalidone—Hypersensitivity—Methotrexate—testicular cancer	0.0014	0.0014	CcSEcCtD
Chlorthalidone—Asthenia—Methotrexate—testicular cancer	0.00136	0.00136	CcSEcCtD
Chlorthalidone—Hypersensitivity—Epirubicin—testicular cancer	0.00131	0.00131	CcSEcCtD
Chlorthalidone—Urticaria—Doxorubicin—testicular cancer	0.00131	0.00131	CcSEcCtD
Chlorthalidone—Abdominal pain—Doxorubicin—testicular cancer	0.0013	0.0013	CcSEcCtD
Chlorthalidone—Diarrhoea—Methotrexate—testicular cancer	0.0013	0.0013	CcSEcCtD
Chlorthalidone—Asthenia—Epirubicin—testicular cancer	0.00128	0.00128	CcSEcCtD
Chlorthalidone—Dizziness—Methotrexate—testicular cancer	0.00126	0.00126	CcSEcCtD
Chlorthalidone—Diarrhoea—Epirubicin—testicular cancer	0.00122	0.00122	CcSEcCtD
Chlorthalidone—Hypersensitivity—Doxorubicin—testicular cancer	0.00121	0.00121	CcSEcCtD
Chlorthalidone—Vomiting—Methotrexate—testicular cancer	0.00121	0.00121	CcSEcCtD
Chlorthalidone—Rash—Methotrexate—testicular cancer	0.0012	0.0012	CcSEcCtD
Chlorthalidone—Dermatitis—Methotrexate—testicular cancer	0.0012	0.0012	CcSEcCtD
Chlorthalidone—Headache—Methotrexate—testicular cancer	0.00119	0.00119	CcSEcCtD
Chlorthalidone—Asthenia—Doxorubicin—testicular cancer	0.00118	0.00118	CcSEcCtD
Chlorthalidone—Dizziness—Epirubicin—testicular cancer	0.00118	0.00118	CcSEcCtD
Chlorthalidone—Vomiting—Epirubicin—testicular cancer	0.00113	0.00113	CcSEcCtD
Chlorthalidone—Nausea—Methotrexate—testicular cancer	0.00113	0.00113	CcSEcCtD
Chlorthalidone—Diarrhoea—Doxorubicin—testicular cancer	0.00113	0.00113	CcSEcCtD
Chlorthalidone—Rash—Epirubicin—testicular cancer	0.00112	0.00112	CcSEcCtD
Chlorthalidone—Dermatitis—Epirubicin—testicular cancer	0.00112	0.00112	CcSEcCtD
Chlorthalidone—Headache—Epirubicin—testicular cancer	0.00111	0.00111	CcSEcCtD
Chlorthalidone—Dizziness—Doxorubicin—testicular cancer	0.00109	0.00109	CcSEcCtD
Chlorthalidone—Nausea—Epirubicin—testicular cancer	0.00106	0.00106	CcSEcCtD
Chlorthalidone—Vomiting—Doxorubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Chlorthalidone—Rash—Doxorubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Chlorthalidone—Dermatitis—Doxorubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Chlorthalidone—Headache—Doxorubicin—testicular cancer	0.00103	0.00103	CcSEcCtD
Chlorthalidone—Nausea—Doxorubicin—testicular cancer	0.000977	0.000977	CcSEcCtD
